Hepatitis C virus (HCV) RNA screening and sequencing using dry plasma spots
Approximately 50% of HCV carriers worldwide remain undiagnosed [1]. There have been calls for expanded HCV testing, based upon the proven efficacy of treatment in reducing morbidity and mortality and preventing transmission [2 –4]. Recommendations for HCV screening are based on testing needs in different populations [2], which must be informed by epidemiological data.
Source: Journal of Clinical Virology - Category: Virology Authors: Anna Maria Geretti, Simon King, Kwabena Adjei-Asante, Lambert Appiah, Dorcas Owusu, Fred Stephen Sarfo, David Chadwick, Richard Odame Phillips, Apostolos Beloukas Tags: Short communication Source Type: research